The primary endpoint is objective response rate, with progression-free survival a key secondary endpoint. The study includes a pre-registration step for arm determination by the molecular tumor board.

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

Moderna ( NASDAQ: MRNA) Q4 2024 Earnings Conference Call February 14, 2025 8:00 AM ET Lavina Talukdar - Senior Vice President, Investor Relations Stephane Bancel - Chief Executive Officer Jamey Mock - ...

Lead singer Lane Moore discusses holding back new music for five years and how Valentine's Day became the perfect release ...

With Captain America: Brave New World now out in theaters, Marvel Phase 5 is almost over ... everything comes to a head in the Loki season 2 finale when the God of Mischief finally finds a ...

Ascona Group, the 7th largest UK independent forecourt operator and one of the fastest growing companies in Wales, has ...

Bayern Munich head coach Vincent Kompany spoke to the media ahead of the big Bundesliga game against Bayer Leverkusen.

Moderna Inc . (BMV:MRNA) reported its fourth-quarter earnings for 2024, revealing a significant decline in revenue and a net loss. The company's earnings per share (EPS) were lower than expected, and ...